U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06921291) titled 'Role of Salbutamol in the Management of Transient Tachypnea of the New Born' on March 27.
Brief Summary: Role of Salbutamol in the management of transient tachypnea of the new born
Study Start Date: Aug. 01, 2024
Study Type: INTERVENTIONAL
Condition:
TTN
Intervention:
DRUG: Salbutamol (Ventolin(R))
Randomized controlled trials
Recruitment Status: COMPLETED
Sponsor: Khyber Teaching Hospital
Information provided by (Responsible Party): Hayat Ullah, Khyber Teaching Hospital
Published by HT Digital Content Services with permission from Health Daily Digest....